help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Elbein, S. C.
Right arrow Articles by Hasstedt, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Elbein, S. C.
Right arrow Articles by Hasstedt, S.

Journal of Clinical Endocrinology & Metabolism, Vol 81, 4422-4427, Copyright © 1996 by Endocrine Society


ARTICLES

Role of the beta 3-adrenergic receptor locus in obesity and noninsulin- dependent diabetes among members of Caucasian families with a diabetic sibling pair

SC Elbein, M Hoffman, K Barrett, K Wegner, C Miles, K Bachman, D Berkowitz, AR Shuldiner, MF Leppert and S Hasstedt
Department of Medicine, Department of Veterans Affairs, Salt Lake City, Utah, USA.

Obesity and insulin resistance are important risk factors for the development of noninsulin-dependent diabetes (NIDDM) and are prevalent among predisposed first degree relatives of diabetic individuals. Recent molecular screening and analysis of a common missense mutation of the beta 3-adrenergic receptor gene suggested this locus as a strong candidate for increased obesity, earlier age of diabetes onset, and insulin resistance. To test the hypothesis that the beta 3-adrenergic receptor locus affects diabetes susceptibility, obesity as measured by body mass index, and components of the insulin resistance syndrome, we examined the role of this region in families ascertained for two or more NIDDM siblings. Linkage analysis was conducted using both parametric and nonparametric analyses, including multipoint sibling pair analysis. We found no evidence for linkage to NIDDM as a dichotomous trait and no evidence for linkage to body mass index, waist/hip ratio, insulin levels, or glucose levels as quantitative traits or to reported age of onset among NIDDM individuals. The Trp64 Arg missense mutation was present in 11% of the population. The mutation was not associated with NIDDM, and Arg64 carriers did not have earlier NIDDM onset, higher body mass index, or higher waist/hip ratio than Trp64 homozygotes. Among relatives, Arg64 carriers had significantly lower fasting glucose levels and lower waist/hip ratios than Trp64 homozygotes, but no characteristics of the insulin resistance syndrome. We conclude that the beta 3-adrenergic receptor locus does not play an important role in NIDDM susceptibility or in the insulin resistance syndrome among members of families with a strong predisposition to NIDDM.


This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. Sweeney, R. K. Wolff, T. Byers, K. B. Baumgartner, A. R. Giuliano, J. S. Herrick, M. A. Murtaugh, W. S. Samowitz, and M. L. Slattery
Genetic Admixture among Hispanics and Candidate Gene Polymorphisms: Potential for Confounding in a Breast Cancer Study?
Cancer Epidemiol. Biomarkers Prev., January 1, 2007; 16(1): 142 - 150.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
T. Oizumi, M. Daimon, T. Saitoh, W. Kameda, H. Yamaguchi, H. Ohnuma, M. Igarashi, H. Eguchi, H. Manaka, M. Tominaga, et al.
Genotype Arg/Arg, but not Trp/Arg, of the Trp64Arg Polymorphism of the {beta}3-Adrenergic Receptor Is Associated With Type 2 Diabetes and Obesity in a Large Japanese Sample
Diabetes Care, September 1, 2001; 24(9): 1579 - 1583.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
V. S. Susulic, L. LaVallette, E. Duzic, L. Chen, D. Shuey, S. K. Karathanasis, and K. E. Steiner
Expression of the Human {beta}3-Adrenergic Receptor Gene in SK-N-MC Cells Is Under the Control of a Distal Enhancer
Endocrinology, May 1, 2001; 142(5): 1935 - 1949.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Walston, K. Silver, H. Hilfiker, R. E. Andersen, M. Seibert, B. Beamer, J. Roth, E. Poehlman, and A. R. Shuldiner
Insulin Response to Glucose Is Lower in Individuals Homozygous for the Arg 64 Variant of the {beta}-3-Adrenergic Receptor
J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4019 - 4022.
[Abstract] [Full Text]


Home page
Pharmacol. Rev.Home page
N. Dzimiri
Regulation of beta -Adrenoceptor Signaling in Cardiac Function and Disease
Pharmacol. Rev., September 1, 1999; 51(3): 465 - 502.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Büettner, A. Schäffler, H. Arndt, G. Rogler, J. Nusser, B. Zietz, I. Enger, S. Hügl, A. Cuk, J. Schölmerich, et al.
The Trp64Arg Polymorphism of the {beta} 3-Adrenergic Receptor Gene Is Not Associated with Obesity or Type 2 Diabetes Mellitus in a Large Population-Based Caucasian Cohort
J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2892 - 2897.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
T. Fujisawa, H. Ikegami, Y. Kawaguchi, and T. Ogihara
Meta-Analysis of the Association of Trp64Arg Polymorphism of {beta}3-Adrenergic Receptor Gene with Body Mass Index
J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2441 - 2444.
[Abstract] [Full Text]


Home page
J. Nutr.Home page
S. C. Elbein
The Genetics of Human Noninsulin-Dependent (Type 2) Diabetes Mellitus
J. Nutr., September 1, 1997; 127(9): 1891 - 1891.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1996 by The Endocrine Society